Evaluating the concordance between BICLA and SRI4 in patients with systemic lupus erythematosus from the placebo arms of the EXPLORER and ATHOS trials

Evaluating the concordance between BICLA and SRI4 in patients with systemic lupus erythematosus from the placebo arms of the EXPLORER and ATHOS trials

Objective The British Isles Lupus Assessment Group (BILAG)-based Composite Lupus Assessment (BICLA) and the Systemic Lupus Erythematosus Responder Index 4 (SRI4) responses are the most common primary endpoints in SLE clinical trials. We examined the concordance and the reasons for discordance in BIC...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria Dall’Era, Edward M Vital, Anca D Askanase, Jorge A Ross Terres, Justine Maller, Oliver Meier, Armando Turchetta, Huiyan (Ashley) Mao
Format: Article
Language:English
Published: BMJ Publishing Group 2025-05-01
Series:Lupus Science and Medicine
Online Access:https://lupus.bmj.com/content/12/1/e001483.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://lupus.bmj.com/content/12/1/e001483.full

Similar Items